Skip to main content
CTIS.
EU
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
EN — English
BG — Български
CS — Čeština
DA — Dansk
DE — Deutsch
EL — Ελληνικά
ES — Español
ET — Eesti
FI — Suomi
FR — Français
GA — Gaeilge
HR — Hrvatski
HU — Magyar
IT — Italiano
LT — Lietuvių
LV — Latviešu
MT — Malti
NL — Nederlands
PL — Polski
PT — Português
RO — Română
SK — Slovenčina
SL — Slovenščina
SV — Svenska
NO — Norsk
CTIS.
EU
✕
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
Notice
This is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
CTIS.eu
›
Drugs
› Dengue Virus, Serotype 2, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 1, Surface Proteins, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 3, Surface Proteins, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 4, Surface Proteins, Live, Attenuated
Dengue Virus, Serotype 2, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 1, Surface Proteins, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 3, Surface Proteins, Live, Attenuated, Dengue Virus, Serotype 2, Expressing Dengue Virus, Serotype 4, Surface Proteins, Live, Attenuated
1 trials
1 recruiting
J
Anti-infectives
Filter these 1 trials by condition, phase, country and more.
Open in Search →
1
Registered trials
1
Recruiting
0
Completed trials
2
Sponsors
1
Countries
Phase IV
Phase IV:
1
Sponsors using this IMP
Region Vaesterbotten
1
Umea University
1
All trials
1 total
An open non-randomized phase IV trial examining interfering cross-reactivity in serological diagnostics of flavivirus infections in Swedish …
Recruiting
2025-520655-92-00
Phase IV
1 country
Region Vaesterbotten; Umea University
Showing 1–1 of 1 trials
← All drugs A–Z